Latest Articles

Read the latest release articles and learn without limits.

0

Hereditary Transthyretin Amyloidosis (HATTR) Market Development Status In 2031 | Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena, Lonis Pharmaceuticals, Eidos Therapeutics, Corino Therapeutics Inc

[New York, October 2024] Hereditary Transthyretin Amyloidosis (HATTR) is a rare and debilitating genetic disorder that arises from mutations in the transthyretin […]